Medipal Holdings - 股票

Medipal Holdings 投资回报率 2024

Medipal Holdings 投资回报率

0.08

股票代码

7459.T

ISIN

JP3268950007

WKN

897036

在2024年,Medipal Holdings的资本回报率(ROCE)为0.08,相较于前一年的0.09 ROCE,增长了-8.36%

Medipal Holdings Aktienanalyse

Medipal Holdings在做什么?

Medipal Holdings Corp is a leading Japanese company operating in various areas of the healthcare industry. Founded in 1995, the company has emerged as a key player in the Japanese healthcare sector and beyond. The company operates in different sectors to offer a wide range of products and services. These segments include wholesale and retail distribution of pharmaceuticals and healthcare products, hospital management, pharmaceutical manufacturing and medical technology, as well as pharmaceutical research and development. Medipal Holdings Corp's business model is to provide a complete supply chain in the healthcare industry, ranging from the manufacturing of pharmaceuticals and medical technology to the supply of doctors and hospitals. The company aims to provide a broad range of healthcare products and services that meet the needs of patients and healthcare providers. The pharmaceutical and healthcare products segment has made the company one of the leading distributors in Japan. Medipal Holdings Corp is a key partner for international companies looking to enter the Japanese market. This segment works closely with various medical facilities to ensure the smooth distribution of drugs and products. It also operates a retail chain of pharmacies that focuses on patient consultation. Hospital management is another important segment of Medipal Holdings Corp. The company is a major operator of hospitals in Japan and also operates senior facilities in the country. It is committed to high-quality medical care and improving the patient experience in its facilities. The company has also developed a program for international patients to meet the needs of foreign patients. The manufacturing of pharmaceuticals and medical technology is another important part of Medipal Holdings Corp's business. The company produces generics and also has partnerships with international pharmaceutical companies for the import and distribution of pharmaceutical products. Medipal Holdings Corp also invests in the research and development of new drugs and medical technology. The pharmaceutical research and development segment is one of Medipal Holdings Corp's newest initiatives. The company invests in the research of new drugs and medical technologies to expand its offering of healthcare products and services. It has its own research and development center as well as partnerships with other companies and institutions. In summary, Medipal Holdings Corp is a key player in the Japanese healthcare industry. The company has developed a wide range of healthcare products and services to meet the needs of patients and healthcare providers. It aims to provide a complete supply chain in the healthcare industry, ranging from the manufacturing of pharmaceuticals and medical technology to the supply of doctors and hospitals. Medipal Holdings Corp has a strong position in the pharmaceutical and healthcare products market as well as in hospital management, and is committed to improving the patient experience and researching new healthcare products. Medipal Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

投资回报率的详细信息

Medipal Holdings的资本投入回报率(ROCE)解读

Medipal Holdings的资本投入回报率(ROCE)是一个财务指标,用来衡量公司对投入资本的盈利能力和效率。它是通过将税前利息和税款前的利润(EBIT)除以投入的资本来计算的。较高的ROCE表示公司能有效地利用其资本来盈利。

年度对比

Medipal Holdings的ROCE年度分析提供了对其资本投入利用效率的有价值的见解。ROCE的增加可能预示着改善的盈利能力和运营效率,而下降可能在资本使用或业务运作中指出潜在的问题。

对投资的影响

Medipal Holdings的ROCE是投资者和分析师在评估公司效率和盈利能力时的关键因素。较高的ROCE可能会使该公司成为一个吸引人的投资,因为这通常表明该公司能获得充足的资本投入收益。

解读ROCE的波动

Medipal Holdings的ROCE变动由EBIT或投入资本的变动引起。这些波动为公司的运营效率、财务表现和策略性财务管理提供了见解,并帮助投资者做出明智的决策。

关于Medipal Holdings股票的常见问题

Medipal Holdings今年的ROCE(投入资本回报率)有多高?

Medipal Holdings今年的ROCE为0.08 undefined。

Medipal Holdings的ROCE(资本运用回报率)与去年相比有何变化?

相比去年,Medipal Holdings的ROCE已经下降了-8.36%。

对Medipal Holdings的投资者来说,高ROCE(资本运营回报率)意味着什么?

高ROCE(资本运用回报率)意味着Medipal Holdings有效地使用了他的资本并且可以实现更高的投入资本回报。这对投资者可能具有吸引力。

对Medipal Holdings的投资者来说,较低的ROCE(投入资本回报率)意味着什么?

一个较低的ROCE(投入资本回报率)可能表明Medipal Holdings在利用其资本方面效率较低,可能难以在其投入的资本上获得适当的回报。这对投资者来说可能存在不确定性或缺乏吸引力。

Medipal Holdings的ROCE增加会对公司产生什么影响?

ROCE的增加Medipal Holdings可能是公司效率提高的指标,并显示出它相对于其投资获得了更高的利润。

Medipal Holdings的ROCE降低会对公司产生什么影响?

ROCE的降低Medipal Holdings可能是公司效率下降的指标,并显示它相对于其投资获得了较低的收益。

有哪些因素可能影响Medipal Holdings的ROCE?

影响Medipal Holdings的ROCE的一些因素包括资产管理效率、投资盈利能力、成本效率和市场情况。

为什么Medipal Holdings的ROCE对投资者如此重要?

Medipal Holdings的ROCE对投资者很重要,因为它是衡量公司效率的指标,显示出公司相对于其投资的成功程度。高ROCE可能表明公司的财务表现强劲。

Medipal Holdings可以采取哪些战略措施来提高ROCE?

为了提高Medipal Holdings的ROCE,可以采取包括提高资产效率、优化投资、节约成本和开发新的收入来源等措施。公司进行全面审查其业务活动以确定最佳策略措施以提高ROCE是非常重要的。

Medipal Holdings支付多少股息?

在过去的12个月中,Medipal Holdings支付了60 JPY 的股息。这相当于大约2.46 %的股息收益率。在未来的12个月内,Medipal Holdings预计将支付62.18 JPY的股息。

Medipal Holdings的股息收益率有多高?

Medipal Holdings当前的股息收益率为2.46 %。

Medipal Holdings什么时候支付股息?

Medipal Holdings按季度支付股息。这些股息将在, , , 月份分发。

Medipal Holdings的股息有多安全?

Medipal Holdings 在过去23年里每年都支付了股息。

Medipal Holdings的股息有多高?

预计未来12个月的股息将达到62.18 JPY。这相当于2.55 %的股息收益率。

Medipal Holdings位于哪个行业?

Medipal Holdings 被分配到“健康”板块。

Wann musste ich die Aktien von Medipal Holdings kaufen, um die vorherige Dividende zu erhalten?

要获得Medipal Holdings在支付的30 JPY的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Medipal Holdings最后一次支付股息是什么时候?

上一次股息发放日期为。

Medipal Holdings在2023年的股息是多少?

在2023年,Medipal Holdings 分配了53 JPY作为股息。

Medipal Holdings 的股息是以哪种货币支付的?

Medipal Holdings的股息将以JPY的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Andere Kennzahlen von Medipal Holdings

我们对Medipal Holdings 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Medipal Holdings 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: